Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02074891 · ClinicalTrials.gov registry record
Sustainable Healthcenter Implementation PrEP Pilot Study
A clinical trial of HIV Pre-exposure Prophylaxis and HIV Chemoprophylaxis, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- 1,420
- Enrollment target
- 5
- Study locations
NCT02074891: Completed study of HIV Pre-exposure Prophylaxis and HIV Chemoprophylaxis, sponsored by Centers for Disease Control and Prevention.
NCT02074891 is a study of HIV Pre-exposure Prophylaxis and HIV Chemoprophylaxis that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,420 participants, above the 755-participant average among 8 other HIV Pre-exposure Prophylaxis trials with a reported enrollment target (88% higher). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02074891, a study of HIV Pre-exposure Prophylaxis and HIV Chemoprophylaxis, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- 1,420 participants
- Enrollment target
- 5
- Study locations
Study Summary
A health services implementation pilot study, conducted with an observational cohort of HIV-uninfected persons including men who have sex with men, heterosexual women and men, and injection drug users receiving daily oral antiretroviral preexposure prophylaxis (PrEP) at four federally qualified health centers that provide sexual health and primary care services to communities with high HIV incidence/prevalence.
Primary Outcome
Side effects, rates of renal adverse events, rates of atraumatic bone fractures, HIV infections with/without virus with mutations associated with TDF or FTC resistance, documented at clinical visits while prescribed PrEP
Conditions Studied
Interventions
- DRUG coformulated TDF/FTC
Study Locations (5)
Illinois
- Access Community Health Network - Grand Boulevard Health and Specialty Center - Chicago
- Howard Brown Community Health Center - Chicago
District of Columbia
- Whitman Walker Health - Washington D.C.
Mississippi
- Open Arms Healthcare Center - Jackson
Pennsylvania
- Strawberry Mansion Health Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,420 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-11 |
What the finished NCT02074891 record still lists
NCT02074891 is an observational study that tracks outcomes without assigning an intervention. Its 1,420 participants enrollment target places it among the larger protocols in the corpus, above the 755-participant average among 8 other HIV Pre-exposure Prophylaxis trials with a reported enrollment target (88% higher).
The record links to 2 conditions, with HIV Pre-exposure Prophylaxis appearing as the primary indexed condition, and to 1 intervention - of which coformulated TDF/FTC is the first listed.
NCT02074891 lists 5 locations in 4 states (Illinois, District of Columbia, Mississippi).
Frequently Asked Questions
What is clinical trial NCT02074891 about?
NCT02074891 is a clinical study titled "Sustainable Healthcenter Implementation PrEP Pilot Study". A health services implementation pilot study, conducted with an observational cohort of HIV-uninfected persons including men who have sex with men, heterosexual women and men, and injection drug users receiving daily oral antiretroviral preexposure prophylaxis (PrEP) at four federally qualified heal...
What is the current status of trial NCT02074891?
This trial is currently completed. The enrollment target is 1,420 participants. The study started on 2014-10. Estimated completion is 2018-11.
What conditions does trial NCT02074891 study?
This clinical trial studies the following conditions: HIV Pre-exposure Prophylaxis, HIV Chemoprophylaxis.
What interventions are being tested in trial NCT02074891?
The interventions under investigation include: coformulated TDF/FTC (DRUG).
Who is sponsoring clinical trial NCT02074891?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02074891 being conducted?
This trial has 5 study locations across District of Columbia, Illinois, Mississippi, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Pre-exposure Prophylaxis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02074891's enrollment target sits among peer trials
1,420 2nd of 8 the highest of 8 other HIV Pre-exposure Prophylaxis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Pre-exposure Prophylaxis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
RECRUITING · Phase 4
-
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
RECRUITING · Phase 3
-
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
RECRUITING · Phase 3
-
Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men
ACTIVE NOT RECRUITING · NA
-
A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05890404 · 1,410 participants · NA
SGM Evidenced-Based Mental Healthcare Implementation
- NCT07042451 · 1,410 participants · NA
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
- NCT07222566 · 1,410 participants · Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT05992935 · 1,405 participants · Phase 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia